Key facts
- This page summarizes Dr. Marlow Hernandez's Form 4 filing for Cano Health, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Jul 2023, 20:01.
Dr. Marlow Hernandez - 12 Jul 2023 Form 4 Insider Report for Cano Health, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 12 Jul 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Jul 2023, 20:01:22 UTC
- Prior SEC filing
- 02 Jun 2023
- Next SEC filing
- 25 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ David J. Armstrong, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Dr. Marlow Hernandez filed Form 4 for Cano Health, Inc. on 14 Jul 2023.
Change
- Previous filing in this sequence was filed on 02 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CANO
transaction
Class A Common Stock
Award
- Transaction value
- Shares
- +189,681
- Change %
- +4%
- Price
- Shares after
- 4,942,605
- Date
- 12 Jul 2023
- Ownership
- Direct
- Footnotes
- F1, F2
CANO
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 67,597
- Date
- 12 Jul 2023
- Ownership
- See Footnote
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These securities represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest on the earliest of (i) July 12, 2024 or (ii) the Issuer's next annual meeting of stockholders, in each case so long as the reporting person remains in service as a member of the board on such date.
Footnote F2
Includes shares previously purchased by the reporting person under the Cano Health, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d) inadvertently excluded from the reporting person's prior filings.
Footnote F3
These shares are held indirectly by the reporting person through the Marlow B. Hernandez 2020 Family Trust.